In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Validation ? a short guide part III Formal requirements of the Polish Patent Office to file validation

Validating European Patent in Poland seems to be a fairly simple task. However, one should Czytaj dalej

Information Claim in Industrial Property Law. Part 2

The previous article presented an informational claim, including its genesis and the previous regulation in Czytaj dalej

Amendments to the Polish Law on Industrial Property – novelties in trademarks and industrial designs [article in The Trademark Lawyer]

Author: Joanna Rafalska, Polish and European Trademark and Design Attorney. In the circles of Polish Czytaj dalej